Burden of infections and preventive strategies in patients with relapsed/refractory multiple myeloma treated with bispecific antibodies - Poll - MDSpire

Infection Risks and Preventive Approaches in Relapsed/Refractory Multiple Myeloma Patients Undergoing Treatment with Bispecific Antibodies

  • By

  • Sorina-Nicoleta Badelita

  • Daniel-Nicolae Murariu

  • Andreea-Lacramioara Mohorea-Neata

  • Sinziana Barbu

  • Larisa Emilia Zidaru

  • Loredana Cirlan

  • Daniel Coriu

  • July 20, 2026

Share

Original Source(s)

Burden of infections and preventive strategies in patients with relapsed/refractory multiple myeloma treated with bispecific antibodies

  • by Sorina-Nicoleta Badelita, Daniel-Nicolae Murariu, Andreea-Lacramioara Mohorea-Neata, Sinziana Barbu, Larisa Emilia Zidaru, Loredana Cirlan, Daniel Coriu

  • July 20, 2026

Related Content

Spatial immune ecology of immunotherapy resistance in gastric and gastroesophageal junction adenocarcinoma

Tumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting

Long-term risk of gynecologic malignancies in postmenopausal women with vaginal bleeding and benign endometrial lesions: a cohort study